ArticleInvestigational new drugs2012

ZJU-6, a novel derivative of Erianin, shows potent anti-tubulin polymerisation and anti-angiogenic activities.

Frankie Lam et al.PubMed ↗Publisher ↗

No numbers read from the abstract.